Work

Abstract A002: Early changes in circulating cell free KRAS G12C as a possible blood-based response biomarker for adagrasib in non-small cell lung cancer (NSCLC).

Year: 2023

Type: conference-abstract

Source: Molecular Cancer Research

DOI: 10.1158/1557-3125.ras23-a002

Authors: Cloud Paweletz, Grace A. Heavey, Yanan Kuang, Thian Kheoh, Kenna Anderes, James Christensen, Pasi A. Jänne

Institutions: Dana-Farber Cancer Institute, Mirati Therapeutics (United States)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367602846

Cites:

Cited by:

Related to: 10